Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade

被引：872

作者：

Benci, Joseph L. ^{[1
,7
]}

Xu, Bihui ^{[1
,7
]}

Qiu, Yu ^{[1
,7
]}

Wu, Tony J. ^{[1
,7
]}

Dada, Hannah ^{[1
,7
]}

Twyman-Saint Victor, Christina ^{[2
,7
]}

Cucolo, Lisa ^{[1
,7
]}

Lee, David S. M. ^{[1
,7
]}

Pauken, Kristen E. ^{[3
,5
]}

Huang, Alexander C. ^{[2
,5
]}

Gangadhar, Tara C. ^{[2
]}

Amaravadi, Ravi K. ^{[2
]}

Schuchter, Lynn M. ^{[2
]}

Feldman, Michael D. ^{[4
]}

Ishwaran, Hemant ^{[8
]}

Vonderheide, Robert H. ^{[2
,5
,6
,7
]}

Maity, Amit ^{[1
]}

Wherry, E. John ^{[3
,5
,6
]}

Minn, Andy J. ^{[1
,5
,6
,7
]}

机构：

[1] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA

[3] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA

[4] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[5] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA

[6] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA

[7] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA

[8] Univ Miami, Dept Epidemiol & Publ Hlth, Div Biostat, Miami, FL 33136 USA

来源：

CELL | 2016年 / 167卷 / 06期

关键词：

CD8(+) T-CELLS; CHRONIC VIRAL-INFECTION; PD-1; BLOCKADE; I INTERFERON; CANCER; THERAPY; EXHAUSTION; RADIATION; RECEPTORS; REJECTION;

D O I：

10.1016/j.cell.2016.11.022

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Therapeutic blocking of the PD1 pathway results in significant tumor responses, but resistance is common. We demonstrate that prolonged interferon signaling orchestrates PDL1-dependent and PDL1-independent resistance to immune checkpoint blockade (ICB) and to combinations such as radiation plus anti-CTLA4. Persistent type II interferon signaling allows tumors to acquire STAT1-related epigenomic changes and augments expression of interferon-stimulated genes and ligands for multiple T cell inhibitory receptors. Both type I and II interferons maintain this resistance program. Crippling the program genetically or pharmacologically interferes with multiple inhibitory pathways and expands distinct T cell populations with improved function despite expressing markers of severe exhaustion. Consequently, tumors resistant to multi-agent ICB are rendered responsive to ICB monotherapy. Finally, we observe that biomarkers for interferon-driven resistance associate with clinical progression after anti-PD1 therapy. Thus, the duration of tumor interferon signaling augments adaptive resistance and inhibition of the interferon response bypasses requirements for combinatorial ICB therapies.

引用

页码：1540 / +

页数：27

共 40 条

[1] Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection [J].

Blackburn, Shawn D. ;

Shin, Haina ;

Haining, W. Nicholas ;

Zou, Tao ;

Workman, Creg J. ;

Polley, Antonio ;

Betts, Michael R. ;

Freeman, Gordon J. ;

Vignali, Dario A. A. ;

Wherry, E. John .

NATURE IMMUNOLOGY, 2009, 10 (01) :29-37

[2] Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade [J].

Blackburn, Shawn D. ;

Shin, Haina ;

Freeman, Gordon J. ;

Wherry, E. John .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (39) :15016-15021

[3]

Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]

[4] Random forests for genomic data analysis [J].

Chen, Xi ;

Ishwaran, Hemant .

GENOMICS, 2012, 99 (06) :323-329

[5] Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes [J].

Cheon, HyeonJoo ;

Stark, George R. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (23) :9373-9378

[6] Type I interferon is selectively required by dendritic cells for immune rejection of tumors [J].

Diamond, Mark S. ;

Kinder, Michelle ;

Matsushita, Hirokazu ;

Mashayekhi, Mona ;

Dunn, Gavin P. ;

Archambault, Jessica M. ;

Lee, Hsiaoju ;

Arthur, Cora D. ;

White, J. Michael ;

Kalinke, Ulrich ;

Murphy, Kenneth M. ;

Schreiber, Robert D. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (10) :1989-2003

[7] ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS [J].

DIGHE, AS ;

RICHARDS, E ;

OLD, LJ ;

SCHREIBER, RD .

IMMUNITY, 1994, 1 (06) :447-456

[8] STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade [J].

Fu, Juan ;

Kanne, David B. ;

Leong, Meredith ;

Glickman, Laura Hix ;

McWhirter, Sarah M. ;

Lemmens, Edward ;

Mechette, Ken ;

Leong, Justin J. ;

Lauer, Peter ;

Liu, Weiqun ;

Sivick, Kelsey E. ;

Zeng, Qi ;

Soares, Kevin C. ;

Zheng, Lei ;

Portnoy, Daniel A. ;

Woodward, Joshua J. ;

Pardoll, Drew M. ;

Dubensky, Thomas W., Jr. ;

Kim, Young .

SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (283)

[9] Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment [J].

Gajewski, Thomas F. ;

Fuertes, Mercedes ;

Spaapen, Robbert ;

Zheng, Yan ;

Kline, Justin .

CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (02) :286-292

[10] The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures [J].

Galon, Jerome ;

Angell, Helen K. ;

Bedognetti, Davide ;

Marincola, Francesco M. .

IMMUNITY, 2013, 39 (01) :11-26

← 1 2 3 4 →